Dock Signal

IOR was described as "an inhibitory effect produced by a peripheral (or exogenous) cue or target.

Main menu

Skip to primary content
Skip to secondary content
  • Home
  • NODAL
    • 3-O-Acetyl-11-keto-β-boswellic
    • Avasimibe
    • Fostamatinib
    • Inavolisib
    • Takinib
  • RNF20
    • JAK Inhibitor I
  • Bafilomycin A1
  • BRD0539
  • mTOR inhibitor
  • Ralimetinib
  • Tocilizumab

RNF20

JAK Inhibitor I : Emerging Drugs for the Treatment of Vitiligo

Proudly powered by WordPress